Sansho Co. Ltd.

Japon

 
Quantité totale PI 17
Rang # Quantité totale PI 87 832
Note d'activité PI 1,8/5.0    10
Rang # Activité PI 89 138
Parent Asahipretec Corporation
Classe Nice dominante Produits chimiques destinés à l'...

Brevets

Marques

8 0
1 0
7 1
0
 
Dernier brevet 2024 - Intraocular pressure lowering ag...
Premier brevet 1979 - Process for improving qualities ...
Dernière marque 2016 - NcPA
Première marque 2016 - NcPA

Industrie (Classification de Nice)

Derniers inventions, produits et services

2023 Invention Intraocular pressure lowering agent, and agent for treating or preventing glaucoma or ocular hype...
2022 Invention Biodegradable padding. [Problem] To safely and efficiently provide padding in which more than 40 ...
2021 Invention Therapeutic agent for pulmonary fibrosis. An object of the present invention is to provide a the...
Invention Therapeutic agent for pulmonary fibrosis. The present invention addresses the problem of providin...
2020 Invention Crystal of cyclic phosphonic acid sodium salt and method for manufacturing same. An object of the...
Invention Crystal of cyclic phosphonic acid sodium salt and method for manufacturing same. An object t of t...
2018 Invention Method for producing sodium cyclic phosphatidic acid. It is an object of the present invention t...
Invention Method for preparing sodium cyclic phosphatidic acid. The present invention addresses the problem...
2016 P/S Chemical preparations containing NcPA for use in the manufacture of pharmaceuticals; chemical pr...
Invention Method for producing fermented bamboo extract and immunostimulating agent. An object of the prese...
2013 Invention Hair growth agent. The purpose of the present invention is to provide a hair growth agent having ...
2012 Invention Therapeutic agent for arthrosis. This invention provides a therapeutic agent for arthrosis exerti...
Invention Therapeutic agent for joint diseases. The purpose of the present invention is to provide a therap...
2010 Invention Nerve cell death inhibitor. Provided is a novel nerve cell death inhibitor which has an effect of...
1999 Invention Coating composition and coating method. A coating composition able to improve the cleanability an...
1993 Invention Percutaneously absorbable crosslinked polyvinylpyrrolidone eperisone or tolperisone preparation. ...
1992 Invention Preparation for endermism containing dopamine derivatives. (C) an unsaturated fatty acid monohydr...
1991 Invention External preparation comprising calcium silicate. An external preparation is characterized by com...
Invention Percutaneously absorbable eperisone or tolperisone preparation. A pharmacological composition for...
1990 Invention Preparation for endermism containing dopamine derivative. ABSTRACT OF THE DISCLOSURE A preparatio...
1989 Invention Pharmaceutical preparation for percutaneous administration containing bunazosin or its salt. A ph...
Invention Pharmaceutical preparation for percutaneous administration containing bunazosin or its salts. ABS...
1988 Invention Pharmaceutical preparation for percutaneous administration containing eperisone or tolperisone or...
1979 Invention Bonding composition for incombustible fibrous materials. A bonding composition for incombustible ...
Invention Process for improving qualities of paper. A process for improving the qualities of paper which co...